Search
News
Downloads
About
Help
Contact
Entity Details
Primary name
FHL1_MOUSE
Entity type
UniProt
Source
Source Link
Details
Accession
P97447
EntryName
FHL1_MOUSE
FullName
Four and a half LIM domains protein 1
TaxID
10090
Evidence
evidence at protein level
Length
280
SequenceStatus
complete
DateCreated
2002-11-15
DateModified
2021-06-02
Ontological Relatives
Genes
Fhl1
GO terms
Show/Hide Table
GO
Name
GO:0003254
regulation of membrane depolarization
GO:0005634
nucleus
GO:0005737
cytoplasm
GO:0005829
cytosol
GO:0005886
plasma membrane
GO:0007517
muscle organ development
GO:0010972
negative regulation of G2/M transition of mitotic cell cycle
GO:0030154
cell differentiation
GO:0030308
negative regulation of cell growth
GO:0043268
positive regulation of potassium ion transport
GO:0044325
transmembrane transporter binding
GO:0046872
metal ion binding
GO:1901016
regulation of potassium ion transmembrane transporter activity
GO:2000134
negative regulation of G1/S transition of mitotic cell cycle
Subcellular Location
Show/Hide Table
Subcellular Location
Cytoplasm
Nucleus
Domains
Show/Hide Table
Domain
Name
Category
Type
IPR001781
Zinc finger, LIM-type
Domain
Domain
IPR042997
Four and a half LIM domains protein 1
Family
Family
Diseases
Show/Hide Table
Drugs
Show/Hide Table
Interactions
13 interactions
Interactor
Partner
Sources
Publications
Link
FHL1_MOUSE
CBX4_HUMAN
BioGRID, MINT
15710417
details
FHL1_MOUSE
TRAF6_MOUSE
IntAct
15102471
details
FHL1_MOUSE
AKA12_MOUSE
IntAct
15102471
details
FHL1_MOUSE
SUH_MOUSE
DIP
24290140
details
FHL1_MOUSE
SRC_HUMAN
BioGRID
29434030
details
FHL1_MOUSE
FERM2_HUMAN
BioGRID
29434030
details
FHL1_MOUSE
SUH_HUMAN
MINT
15710417
details
FHL1_MOUSE
RING1_HUMAN
BioGRID, MINT
15710417
details
FHL1_MOUSE
RET3_HUMAN
BioGRID
15710417
details
FHL1_MOUSE
TLN1_MOUSE
BioGRID
18725486
details
FHL1_MOUSE
FERM2_MOUSE
BioGRID
29434030
details
FHL1_MOUSE
BCLF1_HUMAN
BioGRID
29434030
details
FHL1_MOUSE
CDK1_MOUSE
BioGRID
28094252
details
This website requires cookies in order to function. By using the site you are agreeing to this as outlined in our
Terms of Use
I Agree